×

CancerAnswers@Simmons

Research

Targeting Phosphatidylserine to Boost Immunotherapy Activity

Cancer; Clinical Trials; Research

Targeting Phosphatidylserine to Boost Immunotherapy Activity

February 5, 2025

Latest

Radiation Oncology Clinical Trials Home In on Personalized Treatments

Radiation Oncology Clinical Trials Home In on Personalized Treatments

January 22, 2025

The Rise of Theranostics: A 40-Year Journey

The Rise of Theranostics: A 40-Year Journey

January 15, 2025

Fluorescent Nanoprobe Produces ‘Breakthrough’ for Peritoneal Metastases

Fluorescent Nanoprobe Produces ‘Breakthrough’ for Peritoneal Metastases

November 15, 2023

Therapeutic Targeting of Septin Proteins: A New Pan-Cancer Focus?

Therapeutic Targeting of Septin Proteins: A New Pan-Cancer Focus?

October 25, 2023

Preventing Lineage Plasticity in Prostate Cancer Cells Resensitizes Them to Therapy

Preventing Lineage Plasticity in Prostate Cancer Cells Resensitizes Them to Therapy

May 3, 2023

Top Articles

Targeting Lactate Metabolism for Cancer Immunotherapy - Featured image

Targeting Lactate Metabolism for Cancer Immunotherapy

New study suggests that lactate can rejuvenate immune cells in the fight against cancer and may have additional benefits for immunotherapy.

March 29, 2023

Grants Awarded to Expand Clinical Trials Navigation - Featured image

Clinical Trials; Research

Grants Awarded to Expand Clinical Trials Navigation

Simmons Cancer Center researchers have received funding to help patients from diverse backgrounds access and navigate clinical trials.

March 22, 2023

New Nanotechnology Allows Tissue-Specific Delivery of Genomic Medicines - Featured image

Cancer; Research

New Nanotechnology Allows Tissue-Specific Delivery of Genomic Medicines

Researchers are combining experience in chemical synthesis and nanoparticle engineering with their knowledge of cancer development to design future therapies.

April 30, 2021

AXL Inhibition Restores Response to PD-1 Blockade in STK11/LKB1-mutant NSCLC - Featured image

Lung Cancer; Research

AXL Inhibition Restores Response to PD-1 Blockade in STK11/LKB1-mutant NSCLC

New Simmons Cancer Center research involving investigational drug to target AXL inhibition shows possible benefits for patients with lung adenocarcinomas.

August 15, 2022

All Articles

Targeting Phosphatidylserine to Boost Immunotherapy Activity

Cancer; Clinical Trials; Research

Targeting Phosphatidylserine to Boost Immunotherapy Activity

February 5, 2025

Radiation Oncology Clinical Trials Home In on Personalized Treatments

Breast Cancer; Cancer; Clinical Trials; Research

Radiation Oncology Clinical Trials Home In on Personalized Treatments

January 22, 2025

The Rise of Theranostics: A 40-Year Journey

Cancer; Research

The Rise of Theranostics: A 40-Year Journey

January 15, 2025

Fluorescent Nanoprobe Produces ‘Breakthrough’ for Peritoneal Metastases

Clinical Trials; Research

Fluorescent Nanoprobe Produces ‘Breakthrough’ for Peritoneal Metastases

November 15, 2023

Therapeutic Targeting of Septin Proteins: A New Pan-Cancer Focus?

Cancer; Research

Therapeutic Targeting of Septin Proteins: A New Pan-Cancer Focus?

October 25, 2023

Preventing Lineage Plasticity in Prostate Cancer Cells Resensitizes Them to Therapy

Research; Prostate Cancer

Preventing Lineage Plasticity in Prostate Cancer Cells Resensitizes Them to Therapy

May 3, 2023

Novel Biomarker-Guided Therapeutics Target Glioma Origins

Research; Neuro Oncology

Novel Biomarker-Guided Therapeutics Target Glioma Origins

April 5, 2023

Targeting Lactate Metabolism for Cancer Immunotherapy

Targeting Lactate Metabolism for Cancer Immunotherapy

March 29, 2023

Grants Awarded to Expand Clinical Trials Navigation

Clinical Trials; Research

Grants Awarded to Expand Clinical Trials Navigation

March 22, 2023

12Next